Showing 201 - 220 of 584 results.
The basis of diagnostic investigation of a person with cancer at the time of first presentation.
The outcome of the person's cancer screening test.
The intended outcome of second-line treatment administered to a person with cancer.
An indicator of whether residual tumour is present or absent after the course of treatment for cancer.
The type of screening test the person receives to determine whether further testing is required to diagnose cancer.
A code set representing the type of treatment for cancer.
A code set representing the reference which describes in detail the methods of staging and the definitions for the classification...
An indicator of whether a person with cancer has been referred to psychosocial services as part of their cancer treatment...
An indicator of whether a patient's cancer treatment is discussed and a treatment plan developed at a multidisciplinary team meeting...
The date on which systemic therapy procedure was administered during the course of treatment for cancer.
The scientific/public title and/or registration number of the clinical trial(s) in which the person with cancer is enrolled.
The type of tumour that remains after the course of cancer treatment.
The edition number of the reference used for the purpose of staging a cancer. Refers to the reference that describes in...
The results of oestrogen receptor assay at the time of diagnosis of the primary breast tumour.
An indicator of whether molecular pathology testing was performed to characterise a person's cancer.
An indicator of whether a person with cancer has multiple primary tumours.
The completion date of hormone therapy administered during the course of treatment for cancer.
The start date of hormone therapy administered during the course of treatment for cancer.
The total number of regional lymph nodes examined by a pathologist in a person with cancer.
The results of a molecular pathology test for genetic and molecular abnormalities in a person with cancer.